FDA Investigator Johnna L Bleem

Johnna L Bleem has inspections in 1 countries as of 13 Oct 2023. Johnna L Bleem has collaborated with a combinined 2286 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
28
Last Inspection Date:
13 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alberto A Viciedo, Alice S Tsao, Alison N Stieg, Amy M Codella, Amy M Cramer, Amy N Chen, Anastasia I Onuorah, Anita R Michael, Atul J Agrawal, Benton M Ketron, Bijoy Panicker, Brian J Ryan, Brooke K Higgins, Brooke K Seeman, Bruce G Cooper, Carolyn J Cook, CDR Ileana Barreto Pettit, CDR John Mastalski, Chaltu N Wakijra, Charanjeet Jassal, Christopher Janik, Craig D Zagata, Daniel L Aisen, David M Mcnew, Demitria J Xiradakis, Dennis L Doupnik, Diane T Bargo, Diane T O'brien, Dien N Nguyen, Douglas A Campbell, Douglas C Kovacs, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Elaine E Gilfillan, Emest F Bizjak, Erika E Englund, PhD, Erin L Nagel, Felix Maldonado, Gam S Zamil, Guerlain Ulysse, Harperd, Harry J Brewer, Helen B Ricalde, Hilary K Wagner, James A Liubicich, James D Bridges, James M Mason, James R Birkenstamm, Janet A Rajan, Jazmine N Brown, Jeanette L Mcginnis, Joel R Merriman, John A Podsadowski, John P Mistler, Jonathan W Chapman, Jose O Hernandez, Joseph J Vannelli, Juan Rjimenez Garcia, Kames A Liubicich, Karen L Kosar, Katelyn Astaub Zamperini, Kathryn A Nagy, Kenneth G Klobus, Kevin A Gonzalez, Kim M Downing, King, Ko U Min, Kshitij A Patkar, Lauren E Blaser, Lawrence J Stringer, Linda M Sacco, Marcellinus D Dordunoo, Marcus A Ray, Margaret E Sarles, Marlene L Davis, Mary Alice B Garlipp, Massoud Motamed, Matthew D Schnittker, Melissa J Garcia, Melissa T Roy, Meyer J Slobotsky, Michael A Charles, Michael L Casner, Michael W Burd, Michelle Marsh, Mindy M Chou, Nancy M Espinal, Nealie C Newberger, Nicholas C Mendiola, Niketa Patel, Parul M Patel, Patrick C Klotzbuecher, Paul L Bellamy, Paul Mouris, Paula J Bretz, Pratik S Upadhyay, DDC, Qin Xu, Rabin N Ghoshal, Rachael A Moliver, Rajiv R Srivastava, Randi Lynn Bodoh, Rebecca E Dombrowski, Richard K Glabach, Robert C Steyert, Robert J Martin, Russ E Davis, Sasha M Latonis, Satheesh Thomas, Sean R Marcsisin, Simone E Pitts, Sinai Davis, Sneha Patel, Sneha S Patel, Sony Mathews, State Agency, Stephanie Mangigian, MS/OSH, RN, Stephen J Mottola, Steven J Libal, Syeda N Mahazabin, Tamika White, Tamil Arasu, PhD, Tanya R Syffrard, Tekalign Wondimu, Thomas J Arista, Toyin B Oladimeji, Wendy G Tan, PhD, William A Warnick, William J Leonard, William L Bargo, Yiyue Zhang (nmi), PhD, Yvesna C Blaise

Johnna L Bleem's Documents

Publish Date Document Type Title
July, 2019 FDA 483 Athenex, Inc. - Form 483, 2019-07-11
May, 2019 FDA 483 Unither Manufacturing LLC - Form 483, 2019-05-22
August, 2021 FDA 483 The Skin Atelier, Inc. - Form 483, 2021-08-25
March, 2020 EIR Safetec of America, Inc. - EIR, 2020-03-06
September, 2020 EIR F. M. Howell & Company - EIR, 2020-09-08
May, 2019 FDA 483 Response Unither Manufacturing LLC - Form 483R, 2019-05-22
February, 2022 FDA 483 Frontage Laboratories, Inc. - Form 483, 2022-02-18
June, 2021 FDA 483 Mentholatum Company, The - Form 483, 2021-06-17
April, 2019 FDA 483 Aurohealth LLC - Form 483, 2019-04-11
April, 2019 FDA 483 Response Aurohealth LLC - Form 483R, 2019-05-02
January, 2020 EIR Unither Manufacturing LLC - EIR, 2020-01-10
May, 2019 EIR Unither Manufacturing LLC - EIR, 2019-05-22
July, 2021 FDA 483 Reliant Compounded Solutions Monroe, LLC - Form 483, 2021-07-27
August, 2019 EIR Fresenius Kabi USA, LLC - EIR, 2019-08-12
July, 2019 EIR Athenex, Inc. - EIR, 2019-07-11
December, 2021 FDA 483 Aurora Labs, LLC - Form 483, 2021-12-03
August, 2019 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2019-08-12
August, 2019 FDA 483 Response Fresenius Kabi USA, LLC - Form 483R, 2019-10-21
March, 2020 FDA 483 Safetec of America, Inc. - Form 483, 2020-03-06
November, 2019 FDA 483 Bausch & Lomb Incorporated - Form 483, 2019-11-25
May, 2021 FDA 483 Pine Pharmaceuticals, LLC - Form 483, 2021-05-14
March, 2022 FDA 483 Elementis SRL, Inc. - Form 483, 2022-03-17
February, 2022 EIR Frontage Laboratories, Inc. - EIR, 2022-02-18
February, 2022 FDA 483 Response Frontage Laboratories, Inc. - Form 483R, 2022-03-11
May, 2022 FDA 483 Mylan Pharmaceuticals Inc. - Form 483, 2022-06-22
September, 2021 FDA 483 Arkema Inc. - Form 483, 2021-09-22
September, 2019 FDA 483 Ruspak Corporation - Form 483, 2019-09-13

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more